GlycoCage technology developed by GlycoNet researchers aims to improve current treatments for inflammatory bowel disease.
Catégorie : Network News
GlycoNet-supported startup PanTHERA CryoSolutions acquired by BioLife Solutions
PanTHERA CryoSolutions expands impact of its Ice Recrystallization Inhibitor (IRI) platform through acquisition, continuing to keep operations and talent in Ottawa and Edmonton.
GlycoNet Investigator awarded Jeanne Manery-Fisher Memorial Award
Congratulations to Dr. P. Lynne Howell on receiving the 2025 Jeanne Manery-Fisher Memorial Award from the Canadian Society for Molecular Biosciences.
GlycoNet Board Members Honoured with King Charles III Coronation Medal
Congratulations to Karimah Es Sabar and Dr. Jason Acker on receiving the King Charles III Medal for their contributions to the life sciences.
GlycoNet-supported Zucara Therapeutics Inc. named Emerging Company of the Year
Congratulations to the Zucara Therapeutics team on receiving the 2025 Emerging Company of the Year award from Life Sciences Ontario.
Announcing the 2025 GlycoNet Trainee Association Executive Committee
The committee will support GlycoNet trainees in advancing their skills and knowledge through professional development activities.
GlycoNet Investigator awarded X-Chem Research Excellence Award
Congratulations to Dr. Matthew Macauley on receiving the X-Chem Research Excellence Award.
2024 Wrapped at GlycoNet
Celebrating accomplishments and progress over the past year in glycomics—the science of complex sugars.
Swapping glass slides for DNA-encoded viruses: Advanced tools to study sugar interactions in health and disease
GlycoNet researchers at the University of Alberta have developed two cutting-edge tools to help fine-tune our understanding of sugar molecules called glycans.
Researchers devise a quicker, more efficient way to make life-saving molecules
Improved method for creating nucleoside analogues opens the door to discovering countless treatments for everything from cancer to viral diseases.